October 30-November 2, 2003
18th Annual Meeting

Hyatt Regency
Bethesda, Maryland

  • 18th Annual Meeting Presentations
  • Advances in Radioimmunotherapy of Cancer
    Chaitanya Divgi, MD
  • Cytokine gene polymorphisms, the immune response and angiogenesis in cancer susceptibility and prognosis
    Martin Howell
  • Dendritic Cells Mediate NK Cell Help for TH1 AND CTL Responses: Two-Signal Requirement for NK Cell Helper Function
    Robbie B. Mailliard
  • Adoptive Transfer of Antigen-Specific T Cells in the Treatment of Hematologic Malignancies Following Allogeneic Marrow Transplants
    Richard J. O’Reilly, MD
  • Antibody Mediated Targeting of Tumor Antigens to Human DC Mannose Receptor Enables Efficient Priming of Cytolytic and Helper T cells
    Venky Ramakrishna PhD
  • Amplification of vaccine-induced anti-tumor responses by immunomodulatory cytokines
    David Spaner

October 30, 2003
Primer on Tumor Immunology and Biological Therapy of Cancer

  • Clinical Relevance/Physiologic Determinants and Implications of Hypoxia in Cancer Immunotherapy
    Mark W. Dewhirst, DVM, PhD
  • Cancer Vaccines
    Robert O. Dillman, MD
  • Cytokines
    Robert O. Dillman, MD
  • Introduction to Cancer Biotherapy and Clinical Trials
    Robert O. Dillman, MD
  • Monoclonal Antibodies
    Robert O. Dillman, MD
  • Cell Therapy: A Primer
    Crystal L Mackall MD
  • Heat Shock Proteins (HSP): Principles and Applications for Immunotherapy of cancer
    Antoine Ménoret, PhD
  • Cellular Components of the Anti-Tumor Immune Response
    Julie R. Ostberg, PhD
  • Principles of “Vaccine” Development for Cancer Therapy
    Elizabeth A. Repasky, PhD
  • Humoral Immunity, Antibody Constructs, and Applications to Cancer Immunotherapy
    Paul Sondel MD PhD